| Literature DB >> 36188816 |
Eri Otaka1,2, Kazuyo Oguchi2, Izumi Kondo1, Yohei Otaka3.
Abstract
Background: A self-monitoring approach utilizing fitness trackers that provide feedback regarding physical activities has been recently applied to rehabilitation patients to promote voluntary walking activities. Although this approach has been proven to increase physical activity, it is uncertain whether the intervention improves walking ability. Aim: This review investigated whether the additional self-monitoring approach using activity trackers would improve walking ability in any type of rehabilitation setting.Entities:
Keywords: activity monitors; behavioral change; motivation; pedometers; rehabilitation; self-monitoring; walking ability; wearable devices
Year: 2021 PMID: 36188816 PMCID: PMC9397729 DOI: 10.3389/fresc.2021.752727
Source DB: PubMed Journal: Front Rehabil Sci ISSN: 2673-6861
Figure 1PRISMA flow diagram of the literature search and study selection.
Characteristics of the included studies 1: Study design and methods.
|
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| ||
| Danks et al. ( | RCT | Stroke >6 months, <10,000 steps per day | Outpatients of local clinics, support groups, newspaper advertisements | ( | 3 per week | 12 weeks | StepWatch Activity Monitor | ( | 3 per week | 12 weeks | No |
| Dorsch et al. ( | RCT | Stroke within 35 days | Inpatients of rehabilitation centers | ( | 3 per week | Median 22.5 days (from enroll to discharge) | GulfCoast Data Concepts | ( | 3 per week | Median 20 days (from enroll to discharge) | Yes |
| Kawagoshi et al. ( | RCT | COPD stable for 3 months | Patients at home | ( | Every 2 weeks (exercise supervision) + 1 per month (advice) | 1 year | Kens Lifecorder EX | ( | Every 2 weeks | 1 year | No |
| Mendoza et al. ( | RCT | COPD stable for 4 weeks | Outpatients of public primary health centers | ( | 1 per month | 3 months | PD724 Tanita | ( | 1 per month | 3 months | No |
| Uhm et al. ( | RCT | Breast cancer post primary treatment | Three hospitals (details unknown) | ( | 1 per week | 12 weeks | InBodyBand | ( | Details unknown | 12 weeks | No |
| Mayo et al. ( | RCT | Cancer (various, advanced) fatigue 4–10 by visual analog scale | Outpatients of a University health center | (intervention 1: | 1 per week | 8 weeks | (details unknown) | ( | Details unknown | 8 weeks | No |
| Van Nimwegen et al. ( | RCT | Parkinson's disease Hoehn and Yahr stage ≤ 3 | 32 community hospitals | ( | 1 per month | 24 months | Triaxial accelerometer (details unknown) | ( | 35/year | 24 months | Yes (displays concealed) |
| Goto et al. ( | RCT | Hemophilia | Outpatients of 4 hospitals | ( | (details unknown) | 8 weeks | HJA-350IT Omron | ( | (details unknown) | 8 weeks | Yes (displays concealed) |
| Peel et al. ( | RCT | Geriatric rehabilitation patients | Inpatients of post-acute care geriatric rehabilitation units at 3 sites | ( | 1 per week | median 15 days (4 weeks or until discharge) | ActivPal | ( | (details unknown) | median 14 days (4 weeks or until discharge) | Yes |
| Nicolaï et al. ( | RCT | Peripheral artery diseases: Fontaine stage 2 | Outpatient of 11 vascular surgery clinics | ( | (details unknown) | 12 months | Personal Activity Monitor | (control 1: | 2–3 per week | 12 months | No |
| Smith et al. ( | RCT | Post-total knee arthroplasty 10–18 months postoperatively | Outpatients of surgical follow-up clinics | ( | 1 per week | 16 weeks | Fitbit One, Fitbit Flex | ( | 1 per week | 16 weeks | No |
RCT, randomized controlled trial; COPD, chronic obstructive pulmonary disease.
Characteristics of the included studies 2: Results and other information.
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| Danks et al. ( | (Details unknown) | (a) 6-min walking distance (m) | (a) 0.00 | (Not available) | none | National Institutes of Health | ||
| Dorsch et al. ( | (Details unknown) | (a) 3-min walking distance (m) | (a) −0.60 | (Not available) | None | NIH/NICHD NIH/NCATS | ||
| Kawagoshi et al. ( | (a) 6-min walking distance (m) | (a) −22.00 | (a) 13.20 | None | (Not stated) | |||
| Mendoza | (Details unknown) | 6-min walking distance (m) | 4.40 | 13.10 | None | Fondo Nacional de Investigacion Desarrollo en Salud | ||
| Uhm et al. ( | (Details unknown) | (Details unknown) | (Details unknown) | (a) 2-min walking distance (m) | (a) 3.60 | (Not available) | None | National Information Society Agency funded by the Ministry of Science, ICT and Future Planning |
| Mayo et al. ( | (Details unknown) | 2-min walking distance (m) | (Not available) | (Not available) | None | MUHC and Research Institute of Pilot Project Competition | ||
| Van Nimwegen et al. ( | (Details unknown) | 6-min walking distance (m) | 9.40 | 13.31 | Non | Netherlands Organization for Health Research and Development | ||
| Goto et al. ( | (a) Timed 10-m walk (s) | (a) −0.10 | (Not available) | None | Grants from the Tokyo Physical Therapy Association and the Japan Society for the Promotion of Rehabilitation | |||
| Peel et al. ( | (Details unknown) | Gait speed (self-selected, 3–4 m) (m/s) | 0.01 | 0.04 | None | Australian National Health and Medical Research Council (NHMRC) Grant | ||
| Nicolaï et al. ( | (Details unknown) | (Details unknown) | (a) Absolute claudication distance (m) | (Not available) | (Not available) | None | The Netherlands Organization for Health Research and Development (ZonMw) | |
| Smith et al. ( | (Details unknown) | (Details unknown) | (a) 6-min walking distance (m) | (Not available) | (Not available) | None | FedEx Institute of Technology at the University of Memphis | |
IV, inverse variance method; CI, confidence interval. (†) a significant change from pre- to post-intervention.
Figure 2Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.
Figure 3Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
Figure 4Comparison of walking ability in patients with stroke. (A) Walking endurance (3-min walking distance, m) post-intervention. (B) Gait speed (maximal, m/s) post-intervention. (C) Walking endurance (timed walking distance, m) post-intervention including a study at high risk of bias. (D) Gait speed (maximal, m/s) post-intervention including a study at high risk of bias. SD, standard deviation; IV, inverse variance method; CI, confidence interval.
Figure 5Comparison of walking ability in patients with stable COPD. (A) Walking endurance (6-min walking distance, m) post-intervention. (B) Walking endurance (6-min walking distance, m) change from baseline. SD, standard deviation; IV, inverse variance method; CI, confidence interval.
Figure 6Comparison of walking ability in patients with cancer. Walking endurance (2-min walking distance, m) post-intervention. SD, standard deviation; IV, inverse variance method; CI, confidence interval.
Figure 7Comparison of walking ability in patients with Parkinson's disease. (A) Walking endurance (6-min walking distance, m) post-intervention. (B) Walking endurance (6-min walking distance, m) change from baseline. SD, standard deviation; IV, inverse variance method; CI, confidence interval.
Figure 8Comparison of walking ability in patients with hemophilia. Gait speed (timed 10-m walk, s) post-intervention. SD, standard deviation; IV, inverse variance method; CI, confidence interval.
Figure 9Comparison of walking ability in rehabilitation of geriatric patients. (A) Gait speed (self-selected, m/s) post-intervention. (B) Gait speed (self-selected, m/s) change from baseline. SD, standard deviation; IV, inverse variance method; CI, confidence interval.
Figure 10Comparison of physical functions related to walking ability (secondary outcomes of interest) (17). (A) Knee muscle strength (kg) post intervention in patients with stable COPD, (B) knee muscle strength (kg) change from baseline in patients with stable COPD, (C) knee muscle strength (kg) post intervention in patients with hemophilia, (D) 30-s chair-stand test (no.) post intervention in patients with cancer, (E) handgrip strength (kg) post intervention in cancer, (F) Modified Functional Reach Test (cm) post intervention in patients with hemophilia. SD, standard deviation; IV, inverse variance method; CI, confidence interval.